PER percheron therapeutics limited

FDA approves Sareptas Srp901 for the whole population, page-5

  1. 149 Posts.
    lightbulb Created with Sketch. 16
    @itsagas you are allowed to be wrong but in my opinion you are not allowed to keep switching opinions to whatever soundbites you need that will may PER look like they are going to succeed.

    We have watched you continually post about how good its going to be for PER when Sarepta's application fails and now it hasnt failed. It doesn't matter. If it doesn't matter, than it was never going to help, so what is it.

    We all want PER to win and you are welcome to rejoice when it does.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.8¢
Change
-0.001(5.88%)
Mkt cap ! $8.699M
Open High Low Value Volume
0.8¢ 0.8¢ 0.8¢ $2.01K 251.2K

Buyers (Bids)

No. Vol. Price($)
9 4817091 0.8¢
 

Sellers (Offers)

Price($) Vol. No.
0.9¢ 1969872 4
View Market Depth
Last trade - 15.47pm 04/07/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.